The contribution of naturally occurring IgM antibodies, IgM cross-reactivity and complement dependency in murine humoral responses to pneumococcal capsular polysaccharides

Vaccine

Volumn 27, Issue 42, 2009, Pages 5806-5815

  Jones, Hannah E ^a   Taylor, Philip R ^b   McGreal, Eamon ^b   Zamze, Susanne ^a   Wong, Simon Y C ^a  

^a Churchill Hospital   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibodies; Complement; Polysaccharide vaccines

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; POLYSACCHARIDE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL CAPSULES; COMPLEMENT SYSTEM PROTEINS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNODOMINANT EPITOPES; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED C57BL; STREPTOCOCCUS PNEUMONIAE;

EID: 69749088500     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.063     Document Type: Article

References (66)

1. Goldschneider I., Gotschlich E.C., and Artenstein M.S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 129 (1969) 1307-1326
2. Shinefield H.R., and Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J 19 (2000) 394-397
3. Zangwill K.M., Greenberg D.P., Chiu C.-Y., Mendelman P., Wong V.K., Chang S.-J., et al. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants. Vaccine 21 (2003) 1894-1900
4. Lockhart S. Conjugate vaccines. Expert Rev Vacc 2 (2003) 633-648
5. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 82 (2007) 93-104
6. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297 (2007) 1784-1792
7. Borrow R., Stanford E., Waight P., Helbert M., Balmer P., Warrington R., et al. Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal disease. Infect Immun 76 (2008) 5305-5309
8. Weintraub A. Immunology of bacterial polysaccharide antigens. Carbohydr Res 338 (2003) 2539-2547
9. Wyle F.A., Artenstein M.S., Brandt B.L., Tramont E.C., Kasper D.L., Altieri P.L., et al. Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis 126 (1972) 514-521
10. Taylor P.R., Martinez-Pomares L., Stacey M., Lin H.H., Brown G.D., and Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 23 (2005) 901-944
11. Balázs M., Martin F., Zhou T., and Kearney J.F. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17 (2002) 341-352
12. Haas K.M., Poe J.C., Steeber D.A., and Tedder T.F. B1-a and B1-b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to Streptococcus pneumoniae. Immunity 23 (2005) 7-18
13. Hayakawa K., and Hardy R.R. Development and function of B1-a cells. Curr Opin Immunol 12 (2000) 346-353
14. Kovarik J., Bozzotti P., Tougne C., Davis H.L., Lambert P.-H., Krieg A.M., et al. Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigens. Immunology 102 (2001) 67-76
15. Sen G., Khan A.Q., Chen Q., and Snapper C.M. In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands. J Immunol 175 (2005) 3084-3091
16. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 21 (2003) 335-376
17. Botto M., and Walport M.J. Hereditary disease deficiency of C3 in animals and humans. Int Rev Immunol 10 (1993) 37-50
18. Figueroa J.E., and Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4 (1991) 359-395
19. Markham R.B., Nicholson-Weller A., Schiffman G., and Kasper D.L. The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice. J Immunol 128 (1982) 2731-2733
20. Thyphronitis G., Kinoshita T., Inoue K., Schweinle J.E., Tsokos G.C., Metcalf E.S., et al. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J Immunol 147 (1991) 224-230
21. Wiersma E.J., Kinoshita T., and Heyman B. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur J Immunol 21 (1991) 2501-2506
22. Hazlewood M.A., Kumaratne D.S., Webster D.B., Goodall M., Bird P., and Daha M. An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular antibodies. Clin Exp Immunol 87 (1992) 404-409
23. Drogari-Apiranthitou M., Fijen C.A., Van de Beek D., Hensen E.F., Dankert J., and Kuijper E.J. Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients. Clin Exp Immunol 119 (2000) 311-316
24. Fijen C.A., Kuijper E.J., Drogari-Apiranthitou M., Van Leeuwen Y., Daha M.R., and Dankert J. Protection against meningococcal serogroup ACYW disease in complement deficient individuals vaccinated with the tetravalent meningococccal capsular polysaccharide vaccine. Clin Exp Immunol 114 (1998) 362-369
25. Pozdnyakova O., Guttormsen H.K., Lalani F.N., Carroll M.C., and Kasper D.L. Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J Immunol 17 (2003) 84-90
26. Wessels M.R., Butko P., Ma M., Warren H.B., Lage A.L., and Carroll M.C. Studies of the group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci 92 (1995) 11490-11494
27. Zamze S., Martinez-Pomares L., Jones H., Taylor P.R., Stillion R.J., Gordon S., et al. Recognition of bacterial capsular polysaccharides and lipopolysaccharides by the macrophage mannose receptor. J Biol Chem 277 (2002) 41613-41623
28. Anderson P.W., Pichichero M.E., Insel R.A., Betts R., Eby R., and Smith D.H. Vaccines consisting of periodate-cleaved oligosaccharides from the capsule of Haemophilus influenzae type b coupled to a protein carrier: structural and temporal requirements for priming in the human infant. J Immunol 137 (1986) 1181-1186
29. Higginbotham J.D., Heidelberger M., and Gotschlich E.C. Degradation of a pneumococcal type-specific polysaccharide with exposure of group-specificity. Proc Natl Acad Sci 67 (1970) 138-142
30. Ahearn J.M., Fischer M.B., Croix S., Goerg S., Ma M., Xia J., et al. Disruption of the Cr2 locus results in a reduction in B1-a cells and in an impaired B cell response to T-dependent antigen. Immunity 4 (1996) 251-262
31. Sørensen U.B., Henrichsen J., Chen H.-C., and Szu S.C. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunological methods. Microb Pathog 8 (1990) 325-334
32. Boes M., Prodeus A.P., Schmidt T., Carroll M.C., and Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188 (1998) 2381-2386
33. Jones C., Currie F., and Forster M.J. N.m.r. and conformational analysis of the capsular polysaccharide from Streptococcus pneumoniae type 4. Carbohydr Res 221 (1991) 95-121
34. Kawahara T., Ohdan H., Zhao G., Yang Y.-G., and Sykes M. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J Immunol 171 (2003) 5406-5414
35. Ohdan H., Swenson K.G., Kruger-Gray H.S., Yang Y.-G., Xu Y., Thall A.D., et al. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Galα1,3Gal epitopes in α1,3-galactosyltransferase-deficient mice. J Immunol 165 (2000) 5518-5529
36. Sidorova E.V., Li-Sheng L., Devlin B., Chernishova I., and Gavrilova M. Role of different B-cell subsets in the specific and polyclonal immune response to T-independent antigens type 2. Immunol Lett 88 (2003) 37-42
37. Wardemann H., Boehm T., Dear N., and Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 195 (2002) 771-780
38. Whitmore A.C., Haughton G., and Arnold L.W. Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int Immunol 8 (1996) 533-542
39. Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37 (2000) 1141-1149
40. Ehrenstein M.R., O'Keefe T.L., Davies S.L., and Neuberger M.S. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 95 (1998) 10089-10093
41. Baker N., and Ehrenstein M.R. Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM. J Immunol 169 (2002) 6686-6690
42. Arnold L.W., and Haughton G. Autoantibodies to phosphatidylcholine. The murine antibromelain RBC response. Ann N Y Acad Sci 651 (1992) 354-359
43. Mercolino T.J., Arnold L.W., Hawkins L.A., and Haughton G. Normal mouse peritoneum contains a large population of Ly-1+ (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete haemolytic antibody specific for autologous erythrocytes. J Exp Med 168 (1988) 687-698
44. Lieberman R., Potter M., Mushinski E.B., Humphrey Jr. W., and Rudikoff S. Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med 139 (1974) 983-1001
45. Briles D.E., Claflin J.L., Schroer K., and Forman C. Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae. Nature 294 (1981) 88-90
46. Wuorimaa T., and Kayhty H. Current state of pneumococcal vaccines. Scand J Immunol 56 (2002) 111-129
47. Alugupalli K.R., Leong J.M., Woodland R.T., Muramatsu M., Honjo T., and Gerstein R.M. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 21 (2004) 379-390
48. Casali P., and Schettino E.W. Structure and function of natural antibodies. Curr Top Microbiol Immunol 210 (1996) 167-179
49. Chen J., Borden P., Liao J., and Kabat E.A. Variable region cDNA sequences of three mouse monoclonal anti-idiotypic antibodies specific for anti-alpha(1-6)dextrans with groove- or cavity-type combining sites. Mol Immunol 29 (1992) 1121-1129
50. Baxendale H.E., Johnson M., Stephens R.C., Yuste J., Klein N., Brown J.S., et al. Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. Clin Exp Immunol 151 (2008) 51-60
51. Winkelstein J.A., Bocchini Jr. J.A., and Schiffman G. The role of capsular polysaccharide in the activation of the alternative pathway by pneumococcus. J Immunol 116 (1976) 367-370
52. Horstmann R.D., Pangburn M.K., and Muller-Eberhard H.J. Species specificity of recognition by the alternative pathway of complement. J Immunol 134 (1985) 1101-1104
53. Pangburn M.K. Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size. J Immunol 142 (1989) 2766-2770
54. Sahu A., Kozel T.R., and Pangburn M.K. Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation. Biochem J 302 (1994) 429-436
55. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16 (1998) 545-568
56. Cohn D.A., and Schiffman G. Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens. Infect Immun 55 (1987) 1375-1380
57. Eraklis A.J., Kevy S.V., Diamond L.K., and Gross R.E. Hazard of overwhelming infection after splenectomy in childhood. N Engl J Med 276 (1967) 1225-1229
58. Vinuesa C.G., and MacLennan I.C.M. Antibody responses to polysaccharides. In: Wong S.Y.C., and Arsequell G. (Eds). Immunobiology of carbohydrates (2004), Kluwer Academic/Plenum Publishers, New York, USA 128-147
59. Kruschinski C., Zidan M., Debertin A.S., von Horsten S., and Pabst R. Age-dependent development of the splenic marginal zone in human infants is associated with different causes of death. Human Pathol 35 (2004) 113-121
60. Timens W., Boes A., Rozeboom-Uiterwijk T., and Poppenma S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J Immunol 143 (1989) 3200-3206
61. Fleming S.D., Shea-Donohue T., Guthridge J.M., Kulik L., Waldschmidt T.J., Gipson M.G., et al. Mice deficient in complement receptors 1 and 2 lack a tissue injury inducing subset of the natural antibody repertoire. J Immunol 169 (2002) 2126-2133
62. Reid R.R., Woodcock S., Shimabukuro-Vornhagen A., Austen Jr. W.G., Kobzik L., Zhang M., et al. Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol 169 (2002) 5433-5440
63. Haas K.M., Toapanta F.R., Oliver J.A., Poe J.C., Weis J.H., Karp D.R., et al. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J Immunol 172 (2004) 5833-5837
64. García de Vinuesa C., Gulbranson-Judge A., Khan M., O'Leary P., Cascalho M., Wabl M., et al. Dendritic cells associated with plasmablast survival. Eur J Immunol 29 (1999) 3712-3721
65. 3 antibody responses. Immunity 17 (2002) 713-723
66. Kamboj K.K., Kirchner H.L., Kimmel R., Greenspan N.S., and Schreiber J.R. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein. J Infect Dis 187 (2003) 1629-1638